Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey...

Functional impairment measurement in psoriatic arthritis: Importance and challenges.

Semin Arthritis Rheum. 2018 May 23;:

Mease P, Strand V, Gladman D

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1).

Rheumatology (Oxford). 2018 Jun 25;:

Gottlieb AB, Strand V, Kishimoto M, Mease P, Thaçi D, Birt J, Lee CH, Shuler CL, Lin CY, Gladman DD

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.

J Am Acad Dermatol. 2018 Jun 18;:

Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A

Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database.

Br J Dermatol. 2018 Jun 21;:

Warren RB, Reich K, Langley RG, Strober B, Gladman D, Deodhar A, Bachhuber T, Bao W, Altemeyer E, Hussain S, Safi J

Pages

Senior Scientist, Krembil Research Institute (Krembil)

Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases (part of the UHN Arthritis and Autoimmunity Research Centre)
Co-Director, Lupus Clinic, Toronto Western Hospital (TWH)
Director, Psoriatic Arthritis Program, TWH

Search form

Dafna D Gladman, MD, FRCPC

Related Links

Pages